South Korea Metabolomics Market (2025-2031) | Forecast, Trends, Value, Companies, Analysis, Industry, Outlook, Competitive Landscape, Size & Revenue, Segmentation, Growth, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 South Korea Country Macro Economic Indicators

3.2 South Korea Metabolomics Market Revenues & Volume, 2021 & 2031F

3.3 South Korea Metabolomics Market - Industry Life Cycle

3.4 South Korea Metabolomics Market - Porter's Five Forces

3.5 South Korea Metabolomics Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 South Korea Metabolomics Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.7 South Korea Metabolomics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing focus on personalized medicine and precision healthcare in South Korea

4.2.2 Growing investments in research and development in the field of metabolomics

4.2.3 Rising prevalence of chronic diseases driving the demand for advanced diagnostic technologies

4.3 Market Restraints

4.3.1 Limited awareness and understanding of metabolomics technology among healthcare professionals and patients

4.3.2 High cost associated with metabolomics research and testing

4.3.3 Regulatory challenges and reimbursement issues impacting market growth

6.1 South Korea Metabolomics Market, By Application

6.1.1 Overview and Analysis

6.1.2 South Korea Metabolomics Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 South Korea Metabolomics Market Revenues & Volume, By Biomarker Discovery, 2021- 2031F

6.1.4 South Korea Metabolomics Market Revenues & Volume, By Drug Discovery, 2021- 2031F

6.1.5 South Korea Metabolomics Market Revenues & Volume, By Toxicology Testing, 2021- 2031F

6.1.6 South Korea Metabolomics Market Revenues & Volume, By Nutrigenomics, 2021- 2031F

6.1.7 South Korea Metabolomics Market Revenues & Volume, By Personalized Medicine, 2021- 2031F

6.1.8 South Korea Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.2 South Korea Metabolomics Market, By Indication

6.2.1 Overview and Analysis

6.2.2 South Korea Metabolomics Market Revenues & Volume, By Oncological Disorders, 2021- 2031F

6.2.3 South Korea Metabolomics Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F

6.2.4 South Korea Metabolomics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 South Korea Metabolomics Market Revenues & Volume, By Metabolic Disorders, 2021- 2031F

6.2.6 South Korea Metabolomics Market Revenues & Volume, By Others, 2021- 2031F

6.3 South Korea Metabolomics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 South Korea Metabolomics Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F

6.3.3 South Korea Metabolomics Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F

6.3.4 South Korea Metabolomics Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F

7.1 South Korea Metabolomics Market Export to Major Countries

7.2 South Korea Metabolomics Market Imports from Major Countries

8.1 Adoption rate of metabolomics technologies in clinical practice

8.2 Number of research collaborations and partnerships in the metabolomics sector

8.3 Rate of incorporation of metabolomics data in treatment decision-making

8.4 Funding and grants allocated to metabolomics research projects

8.5 Number of metabolomics-related publications and patents from South Korea

9.1 South Korea Metabolomics Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 South Korea Metabolomics Market Opportunity Assessment, By Indication, 2021 & 2031F

9.3 South Korea Metabolomics Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 South Korea Metabolomics Market Revenue Share, By Companies, 2024

10.2 South Korea Metabolomics Market Competitive Benchmarking, By Operating and Technical Parameters